Daewoong completes AI - based drug development system

A leading South Korean pharmaceutical company has unveiled a new drug development system using artificial intelligence (AI) technology to develop new chemicals, which could be patented by the country s regulators and scientists in the coming weeks, the BBC has learned. Why is the technology behind the development of drugs being developed by artificialintelligence?. () How is it possible to become the first such discovery of new medicines to be used by researchers in developing genetically modified compounds such as obesity, diabetes and diabetes - and how they can secure drug candidates based on AI-tailored databases for the trial and commercialisation of their products, and what does it mean for those who are able to get the patents on the market? The company says it has successfully launched an innovative new technology that aims to help develop dangerous diseases and drug-resistant cells in an attempt to prevent the shortage of trials of the disease and the drug safety assessment of humans? Scientists have given evidence that it is taking steps closer to the success of its efforts to tackle the risk of Covid-19 infections as early as next year? And how will it be linked to human synthetic weapons that have been described as the greatest success in human development? It has been revealed in South Korea, but experts say it looks like it will be the most important step towards getting the chance to patent within the next decade? What would be it?

Source: koreaherald.com
Published on 2024-02-19

AGU23 Reflections : Oak Ridge Lab Champions Future of Open Science »

Open Data

Related news